ArticleslgStudy

chemistry

LEK-8841

LEK-8841 is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand LEK-8841 rather than just read about it. In short: LEK-8841, also known as N-methyl-N-(2-propynyl)-2-bromolysergamide or as 2-bromo-LEK-8842, is a monoamine receptor modulator of the lysergamide family related to 2-bromo-LSD. It is the 2-bromo derivative of LEK-8842.

LEK-8841 — main illustration
LEK-8841 — illustration

Key takeaways

  • LEK-8841 belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect LEK-8841 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of LEK-8841 from memory before moving on to harder problems.

Reference excerpt

LEK-8841, also known as N-methyl-N-(2-propynyl)-2-bromolysergamide or as 2-bromo-LEK-8842, is a monoamine receptor modulator of the lysergamide family related to 2-bromo-LSD. It is the 2-bromo derivative of LEK-8842. The drug shows affinity for serotonin 5-HT2 and α1-adrenergic receptors (Ki = 16.3 nM at 5-HT2) and acts as a silent antagonist of these receptors (A2 = 11.7 nM and 355 nM, respectively), with activity described as qualitatively similar to that of ketanserin but with greater selectivity for serotonin 5-HT2 receptors over α1-adrenergic receptors. However, LEK-8841 was also subsequently found to interact with the dopamine D1 and D2 receptors (Ki = 360 nM and 11.3 nM, respectively). The drug inhibits apomorphine-induced hyperlocomotion and climbing behavior, induces catalepsy, inhibits the 5-hydroxytryptophan (5-HTP)-induced head twitch response, and produces hypotension in rodents. LEK-8841 was first described in the scientific literature by 1992. It was developed by the Slovenian pharmaceutical company LEK Pharmaceuticals. The drug has been suggested as a potential clinically effective antipsychotic for medical use. Based on ratio of dopamine D2 receptor antagonism to serotonin 5-HT2 receptor antagonism, it is said to appear more like a typical than atypical antipsychotic.

See also Substituted lysergamide LEK-8842, LEK-8829, LEK-8822 BOL-148 (2-bromo-LSD)

References

Illustrations

LEK-8841 illustration

Worked examples

Example 1 — a first encounter with LEK-8841

Start with the simplest possible case. Write down what LEK-8841 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to LEK-8841 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about LEK-8841 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of LEK-8841

In research
LEK-8841 appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses LEK-8841 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
LEK-8841 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 5-HT2A antagonists, Abandoned drugs, Alpha-1 blockers, so understanding it makes those chapters shorter.
In everyday life
Look for LEK-8841 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “LEK-8841” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study LEK-8841 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what LEK-8841 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain LEK-8841 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is LEK-8841 in simple terms?

LEK-8841, also known as N-methyl-N-(2-propynyl)-2-bromolysergamide or as 2-bromo-LEK-8842, is a monoamine receptor modulator of the lysergamide family related to 2-bromo-LSD. It is the 2-bromo derivative of LEK-8842.

Why does LEK-8841 matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study LEK-8841?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on LEK-8841.

Tags

  • 5-HT2A antagonists
  • Abandoned drugs
  • Alpha-1 blockers
  • Bromoarenes
  • Carboxamides
  • D2 antagonists
  • Drugs not assigned an ATC code
  • Lysergamides
  • Methyl compounds
  • Propargyl compounds
  • Serotonin receptor modulators

Keep exploring